Epidemiology and clinical course of COVID-19 in Shanghai, China

Author:

Shen Yinzhong1ORCID,Zheng Fang2,Sun Danfeng2,Ling Yun3,Chen Jun1ORCID,Li Feng4,Li Tao5,Qian Zhiping6,Zhang Yuyi6,Xu Qingnian7,Liu Li1,Huang Qin3,Shan Fei8,Xu Lie2,Wu Jun2,Zhu Zhaoqin9,Song Zhigang10,Li Shenyang11,Shi Yuxin8,Zhang Jianliang12,Wu Xueyun1ORCID,Mendelsohn Joshua B.13,Zhu Tongyu14,Lu Hongzhou1ORCID

Affiliation:

1. Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

2. Department of Medical Affairs, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

3. Department of Infection, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

4. Department of Respiratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

5. Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

6. Department of Severe Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

7. Department of Traditional Chinese Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

8. Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

9. Clinical Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

10. P3 Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

11. Data Management Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

12. Department of Gastroenterology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

13. College of Health Professions, Pace University, New York, NY, USA

14. Department of Urology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China

Funder

Shanghai Science and Technology Committee

Ministry of Science and Technology, the People’s Republic of China

Fudan University

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Reference23 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. World Health Organization. Statement on the second meeting of the International Health Regulations. (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, Switzerland: World Health Organization. [Cited 2020 Mar 15]. Available at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).

3. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - Mar 11 2020. [cited 2020 Mar 15]. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.

4. World Health Organization. Coronavirus disease (COVID-19) outbreak situation. [cited 2020 March 25]. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

5. World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. [cited 2020 Jan 24]. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3